AWP
CVS icon

Accretive Wealth Partners’s CVS Health CVS Stock Holding History

Accretive Wealth Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-17,245
Closed -$1.36M – 140
2023
Q4 		$1.36M Buy
17,245
+127
+0.7% +$9.04K 0.65% 56
2023
Q3 		$1.2M Buy
17,118
+373
+2% +$26.4K 0.71% 46
2023
Q2 		$1.16M Buy
16,745
+561
+3% +$39.9K 0.69% 47
2023
Q1 		$1.2M Buy
16,184
+298
+2% +$25K 0.77% 44
2022
Q4 		$1.48M Sell
15,886
-201
-1% -$19.4K 1.02% 30
2022
Q3 		$1.53M Sell
16,087
-159
-1% -$15.7K 1.17% 23
2022
Q2 		$1.5M Sell
16,246
-45
-0.3% -$4.39K 1.09% 27
2022
Q1 		$1.65M Buy
16,291
+113
+0.7% +$11.9K 1.03% 24
2021
Q4 		$1.67M Buy
16,178
+355
+2% +$32.8K 1.06% 21
2021
Q3 		$1.34M Buy
15,823
+597
+4% +$50K 0.95% 29
2021
Q2 		$1.27M Buy
15,226
+2,273
+18% +$186K 0.92% 30
2021
Q1 		$974K Buy
12,953
+1,053
+9% +$76.7K 0.88% 41
2020
Q4 		$813K Buy
+11,900
New +$774K 0.8% 47

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Accretive Wealth Partners's CVS Position: Q1 2024 in Review

Accretive Wealth Partners sold out of CVS Health (CVS) in Q1 2024, closing a stake of 17,245 shares — an estimated $1.36M sold.

Accretive Wealth Partners first reported a position in CVS in Q4 2020 and held it in 13 quarters. The position peaked at $1.67M in Q4 2021. 2,176 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

  • Accretive Wealth Partners reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
  • Accretive Wealth Partners sold 17,245 CVS Health shares in Q1 2024, an estimated $1.36M.
  • Accretive Wealth Partners first reported a position in CVS Health in Q4 2020 and held it in 13 quarters.
  • Accretive Wealth Partners's CVS Health position peaked at $1.67M in Q4 2021.
  • 2,176 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on Accretive Wealth Partners's 13F filing for Q1 2024, filed 6 May 2024.